Handson Global Management Q1 Results: Consolidated loss widens to ₹206.3 lakh
Handson Global Management reported a consolidated net loss of ₹206.27 lakh for Q1FY26, reversing from a profit of ₹172.70 lakh in Q1FY25. Standalone revenue fell 28% YoY to ₹979.50 lakh, leading to a standalone net loss of ₹30.79 lakh. The Board approved a US$ 2 million infusion into HCI-LLC and noted a significant rise in consolidated other expenses.

*this image is generated using AI for illustrative purposes only.
Handson Global Management (HGM) Ltd reported a significant deterioration in financial performance for the first quarter of FY26, with consolidated results swinging from profit to loss. The company posted a consolidated net loss of ₹206.27 lakh for the quarter ended June 30, 2026, compared to a net profit of ₹172.70 lakh in the corresponding period of FY25. This marks a sharp reversal from the previous quarter (Q4FY25), where the group recorded a net loss of ₹215.31 lakh, indicating continued volatility in group-level profitability.
Standalone operations also faced headwinds. Revenue from operations declined 28% year-on-year to ₹979.50 lakh, down from ₹1,360.90 lakh in Q1FY25. Consequently, the standalone entity reported a net loss of ₹30.79 lakh, contrasting with a net profit of ₹172.86 lakh in the same quarter last year. Employee benefits expense remained the largest cost component, accounting for ₹755.22 lakh or approximately 77% of standalone revenue.
Corporate Actions and Subsidiary Infusion
During its meeting on August 14, 2026, the Board of Directors approved several key matters alongside the financial results:
- Capital Infusion: The Board approved an infusion of up to US$ 2 million into its overseas subsidiary, Healthcare Capital Holdings LLC (HCI-LLC), based in the Cayman Islands. This capital contribution aims to fund business and operational requirements, subject to completing FEMA and AD-Bank formalities.
- CSR Policy: The Board reviewed and approved the company’s Corporate Social Responsibility (CSR) policy as per statutory requirements.
- Subsidiary Updates: The consolidated results include wholly owned subsidiaries HOVS LLC (USA) and Healthcare Capital Holdings LLC (USA). Notably, HOVS Holdings Limited (Hong Kong) was dissolved effective May 16, 2025.
Financial Performance Breakdown
The divergence between standalone and consolidated results highlights the impact of overseas operations and inter-company dynamics. While standalone other income stood at ₹29.15 lakh, it included a foreign exchange fluctuation loss of ₹7.19 lakh. In contrast, the consolidated statement showed higher "Other Expenses" at ₹383.47 lakh, up significantly from ₹113.16 lakh in Q1FY25, contributing to the wider group-level loss.
| Metric | Q1FY26 (Unaudited) | Q1FY25 (Unaudited) | Change |
|---|---|---|---|
| Consolidated Revenue | ₹1,079.89 lakh | ₹1,360.90 lakh | -20.6% |
| Consolidated Net Profit/Loss | ₹(206.27) lakh | ₹172.70 lakh | Turned Loss |
| Standalone Revenue | ₹979.50 lakh | ₹1,360.90 lakh | -28.0% |
| Standalone Net Profit/Loss | ₹(30.79) lakh | ₹172.86 lakh | Turned Loss |
What the Numbers Show
A critical observation from the filing is the disparity between standalone and consolidated profitability drivers. While the standalone entity’s loss was primarily driven by high employee costs relative to declining revenue, the consolidated loss was exacerbated by a surge in "Other Expenses." Consolidated other expenses jumped to ₹383.47 lakh in Q1FY26 from ₹113.16 lakh in Q1FY25, representing a more than threefold increase. This suggests that non-operational costs or specific charges at the group level, rather than core operational inefficiencies alone, are weighing heavily on the bottom line. Additionally, the group’s investment in Exela Technologies Inc. is carried at fair value through other comprehensive income (FVOCI), with no impact on the profit and loss statement for the quarter.
The statutory auditors, Lodha & Co LLP, issued a review report with an unmodified conclusion on the unaudited consolidated and standalone financial results.
Historical Stock Returns for HandsOn Global Management (HGM)
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.81% | -6.19% | -10.14% | -24.64% | -12.77% | -34.15% |
What specific operational or strategic initiatives are driving the threefold increase in consolidated 'Other Expenses,' and will these costs persist in future quarters?
How will the approved US$ 2 million capital infusion into Healthcare Capital Holdings LLC impact HGM's cash reserves and overall liquidity position?
Given that employee benefits constitute 77% of standalone revenue, what cost-optimization measures is management implementing to restore profitability amid declining revenues?


































